Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sheenams
    Member
    • Oct 2011
    • 15

    #1

    Cuffdiff output

    I'm using the Tuxedo suite in Galaxy for RNA analysis of Illumina, 30bp single end reads. My mentor would like the output to match what was done in a paired end analysis from a similar experiment, mapped to the Zebrafish Ensembl GTF.

    The previous output looks like this:

    test_id gene_id gene locus sample_1 sample_2
    ENSDARG00000000001 ENSDARG00000000001 slc35a5 9:35060459-35093143 q1 q2
    ENSDARG00000000002 ENSDARG00000000002 ccdc80 9:35060459-35093143 q1 q2
    ENSDARG00000000018 ENSDARG00000000018 nrf1 4:14146776-14169064 q1 q2

    However, the default output of Cuffdiff gives XLOC IDs:

    test_id gene_id gene locus Sample_1 Sample_2
    XLOC_000001 XLOC_000001 ENSDART00000127092 Zv9_NA10:29174-34103 CON REG
    XLOC_000002 XLOC_000002 ENSDART00000130683 Zv9_NA101:39833-39948 CON REG


    How do I map the XLOC IDs to Ensembl IDs for 'gene_id' with gene symbol as the 'gene'? The previous experiment was also mapped to the same Ensembl GTF (or so I've been told), I'm just assuming they did some post-cuffdiff processing of the output files.

    Thanks

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...